Spinocerebellar ataxia type 23 (SCA23): a review
Authors:
- 11 November 2020
- journal article
- review article
- Published by Springer Nature in Journal of Neurology
- Vol. 268 (12) , 4630-4645
Abstract
Spinocerebellar ataxias (SCAs), formerly known as autosomal dominant cerebellar ataxias (ADCAs), are a group of hereditary heterogeneous neurodegenerative diseases. Gait, progressive ataxia, dysarthria, and eye movement disorder are common symptoms of spinocerebellar ataxias. Other symptoms include peripheral neuropathy, cognitive impairment, psychosis, and seizures. Patients may lose their lives due to out of coordinated respiration and/or swallowing. Neurological signs cover pyramidal or extrapyramidal signs, spasm, ophthalmoplegia, hyperactive deep tendon reflexes, and so on. Different subtypes of SCAs present various clinical features. Spinocerebellar ataxia type 23 (SCA23), one subtype of the SCA family, is characterized by mutant prodynorphin (PDYN) gene. Based on literatures, this review details a series of SCA23, to improve a whole understanding of clinicians and point out the potential research direction of this dysfunction, including a history, pathophysiological mechanism, diagnosis and differential diagnosis, epigenetics, penetrance and prevalence, genetic counseling, treatment and prognosis.Keywords
This publication has 95 references indexed in Scilit:
- Hereditary ataxias: overviewGenetics in Medicine, 2013
- Mutations in rare ataxia genes are uncommon causes of sporadic cerebellar ataxiaMovement Disorders, 2012
- Autosomal dominant cerebellar ataxia type I: A review of the phenotypic and genotypic characteristicsOrphanet Journal of Rare Diseases, 2011
- Nucleus Accumbens μ-Opioid Receptors Mediate Social RewardJournal of Neuroscience, 2011
- Depression comorbidity in spinocerebellar ataxiaMovement Disorders, 2011
- Prodynorphin Mutations Cause the Neurodegenerative Disorder Spinocerebellar Ataxia Type 23The American Journal of Human Genetics, 2010
- Dynorphin Opioid Peptides Enhance Acid-Sensing Ion Channel 1a Activity and Acidosis-Induced Neuronal DeathJournal of Neuroscience, 2009
- 30 years of dynorphins — New insights on their functions in neuropsychiatric diseasesPharmacology & Therapeutics, 2009
- Role of Histone H3 Lysine 27 Methylation in Polycomb-Group SilencingScience, 2002
- Dynorphin(1–13) improves survival in cats with focal cerebral ischaemiaNature, 1984